In the literature, it is widely discussed whether the pharmaceutical industry is going through an innovation crisis … progress in biotechnology and related disciplines has increased the opportunities to treat diseases, but the firms have …

essential role in transforming their national innovation systems so that they can be more adaptable to economic development. The … innovation activities. Balancing import of technology and indigenous R&D effort is another major theme. Innovation capability … influence on choice of innovation at the firm level, i.e., the decision at firm level in terms of indigenous R&D or import of …

While most economists believe that public scientific research fuels industry innovation and economic growth, systematic … size as a significant driver of drug innovation in the pharmaceutical industry, but they did not find any evidence … supporting science-driven innovation from publicly funded research. This paper uses new data on biomedical research investments …

Innovation policy involves trading off monopoly output and pricing today in exchange for incentives for firms to …

their innovation activities in response to the potential entry of direct competitors. We then examine a legal ruling that … firms increased their net innovation activities in response to competitive entry. These effects center on firms with … innovation by new entrants after the ruling in response to increased competition. Overall, these results are consistent with …

improved their innovation capability during economic transition. First, we measure and compare innovation capability of both … countries by using not only various input and output indicators of innovation systems but also the contribution of technological … developed their innovation capabilities by focusing on the transformation of their national innovation systems since the …

an innovation rewarding institution. According to our analysis, pharma patents have constituted legal barriers to protect …